Iridoid glycosides from verbascum nigrum ssp. abietinum

1 paper3 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Funders: European Regional Development Fund and 2 more

Model organisms1

Outcomes

hsf-1

upin worms1

1 study

Iridoid glycosides from verbascum nigrum ssp. abietinum increases hsf-1 in worms.
“Additionally, sgk-1/SGK-1, hsf-1/HSF1, and tcer-1/TCERG1 were consistently overexpressed”
Model organisms
Stress endurance mediates the healthspan-promoting effect of two newly described iridoid glycosides from Verbascum nigrum ssp. abietinum in Caenorhabditis elegans
Phytomedicine : international journal of phytotherapy and phytopharmacology9 Feb 2026

Latest

1 in 12 months

Phytomedicine15 Feb

Stress endurance mediates the healthspan-promoting effect of two newly described iridoid glycosides from Verbascum nigrum ssp. abietinum in Caenorhabditis elegans

Experiments in wormsInterventions

Paper

Iridoid glycosides from verbascum nigrum ssp. abietinum

Outcomes

Latest

Stress endurance mediates the healthspan-promoting effect of two newly described iridoid glycosides from Verbascum nigrum ssp. abietinum in Caenorhabditis elegans

Related